AEye Reports Fourth Quarter 2024 Results
Apollo launches in US at CES
On-track for Apollo manufacturing ramp with large global Tier 1 partner
Extended cash runway to mid-2026 with new growth capital
Recent Business Highlights
-
Launched Apollo in the
U.S. with resounding success at CES, showcasing its distinct advantages of behind-the-windshield integration and lower overall system costs - Began production of first Apollo B samples, reaching a critical milestone for quoting process across multiple sectors
- Beat quarterly cash burn guidance for the fourth consecutive quarter
- Raised additional growth capital to ramp Apollo into high-volume production, strengthening balance sheet and extending cash runway to mid-2026
Management Commentary
“We continue to leverage market enthusiasm for our technology to raise additional growth capital and have extended our cash runway to mid-2026. Heading into the new year,
Recent Financial Highlights
-
Cash burn in Q4 2024 was
$4.8 million , beating guidance of$4.9 million -
GAAP net loss in Q4 2024 was
$(8.5) million , or$(0.93) per share, based on 9.1 million weighted average common shares outstanding -
Non-GAAP net loss in Q4 2024 was
$(6.3) million , or$(0.69) per share, based on 9.1 million weighted average common shares outstanding -
Cash, cash equivalents, and marketable securities were
$22.3 million as ofDecember 31, 2024 - Common shares outstanding of 13.7 million at the end of Q4 2024, compared to 6.3 million common shares outstanding at the end of Q4 2023
“We ended the fourth quarter of 2024 with
2025 Financial Outlook
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
Access is also available via:
Conference call: https://aeye.pub/42D3K1p
Webcast: https://aeye.pub/40Dx9FZ
About
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This press release includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, less expenses related to registration statements and common stock purchase agreements, less change in fair value of convertible note and warrant liabilities, plus realized loss on instrument-specific credit risk, plus one-time termination benefits and other restructuring costs, plus non-routine write-downs of inventory, other current assets and losses on purchase commitments, plus long-lived asset disposals and impairment charges, plus loss (gain) on termination of operating lease, net; and
- Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expense, less interest income and other, less interest expense and other, less benefit (provision) for income tax.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements included in this press release include statements about the product manufacturing ramp with a large global Tier 1 partner, the extension of AEye’s cash runway to mid-2026, the potential liquidity available to
Readers are cautioned not to put undue reliance on forward-looking statements;
|
Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||
| As of |
|||||
|
2024 |
2023 |
||||
| ASSETS | |||||
| Current Assets: | |||||
| Cash and cash equivalents |
$ |
10,266 |
$ |
16,932 |
|
| Marketable securities |
|
12,012 |
|
19,591 |
|
| Accounts receivable, net |
|
11 |
|
131 |
|
| Inventories, net |
|
176 |
|
583 |
|
| Prepaid and other current assets |
|
2,706 |
|
2,517 |
|
| Total current assets |
|
25,171 |
|
39,754 |
|
| Right-of-use assets |
|
652 |
|
11,226 |
|
| Property and equipment, net |
|
605 |
|
281 |
|
| Restricted cash |
|
— |
|
2,150 |
|
| Other noncurrent assets |
|
692 |
|
906 |
|
| Total assets |
$ |
27,120 |
$ |
54,317 |
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Current Liabilities: | |||||
| Accounts payable |
$ |
3,598 |
$ |
3,442 |
|
| Accrued expenses and other current liabilities |
|
7,709 |
|
6,585 |
|
| Total current liabilities |
|
11,307 |
|
10,027 |
|
| Operating lease liabilities, noncurrent |
|
479 |
|
14,858 |
|
| Convertible note |
|
146 |
|
— |
|
| Other noncurrent liabilities |
|
64 |
|
409 |
|
| Total liabilities |
|
11,996 |
|
25,294 |
|
| Stockholders’ Equity: | |||||
| Preferred stock |
|
— |
|
— |
|
| Common stock |
|
1 |
|
1 |
|
| Additional paid-in capital |
|
388,213 |
|
366,647 |
|
| Accumulated other comprehensive income |
|
5 |
|
10 |
|
| Accumulated deficit |
|
(373,095) |
|
(337,635) |
|
| Total stockholders’ equity |
|
15,124 |
|
29,023 |
|
| Total liabilities and stockholders’ equity |
$ |
27,120 |
$ |
54,317 |
|
|
Consolidated Statements of Operations (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||
| Three months ended |
Twelve months ended |
||||||||||
|
2024 |
2023 |
2024 |
2023 |
||||||||
| Revenue: | |||||||||||
| Prototype sales |
$ |
6 |
$ |
51 |
$ |
97 |
$ |
477 |
|||
| Development contracts |
|
40 |
|
18 |
|
105 |
|
987 |
|||
| Total revenue |
|
46 |
|
69 |
|
202 |
|
1,464 |
|||
| Cost of revenue |
|
49 |
|
6,668 |
|
778 |
|
15,319 |
|||
| Gross loss |
|
(3) |
|
(6,599) |
|
(576) |
|
(13,855) |
|||
| Operating expenses: | |||||||||||
| Research and development |
|
4,252 |
|
5,178 |
|
16,389 |
|
26,171 |
|||
| Sales and marketing |
|
69 |
|
1,746 |
|
551 |
|
12,528 |
|||
| General and administrative |
|
4,671 |
|
4,955 |
|
18,312 |
|
25,234 |
|||
| Impairment of long-lived assets |
|
— |
|
9,941 |
|
— |
|
9,988 |
|||
| Total operating expenses |
|
8,992 |
|
21,820 |
|
35,252 |
|
73,921 |
|||
| Loss from operations |
|
(8,995) |
|
(28,419) |
|
(35,828) |
|
(87,776) |
|||
| Other income (expense): | |||||||||||
| Change in fair value of convertible note and warrant liabilities |
|
4 |
|
56 |
|
— |
|
(858) |
|||
| Interest income and other |
|
143 |
|
385 |
|
799 |
|
1,317 |
|||
| Interest expense and other |
|
296 |
|
210 |
|
(433) |
|
248 |
|||
| Total other income (expense), net |
|
443 |
|
651 |
|
366 |
|
707 |
|||
| Loss before income tax |
|
(8,552) |
|
(27,768) |
|
(35,462) |
|
(87,069) |
|||
| (Benefit) provision for income tax |
|
(4) |
|
14 |
|
(2) |
|
57 |
|||
| Net loss |
$ |
(8,548) |
$ |
(27,782) |
$ |
(35,460) |
$ |
(87,126) |
|||
| Per Share Data | |||||||||||
| Net loss per common share (basic and diluted) |
$ |
(0.93) |
$ |
(4.44) |
$ |
(4.89) |
$ |
(14.95) |
|||
| Weighted average common shares outstanding (basic and diluted) |
|
9,144,094 |
|
6,257,973 |
|
7,253,683 |
|
5,827,721 |
|||
|
Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||
| Twelve months ended |
|||||
|
2024 |
2023 |
||||
| Cash flows from operating activities: | |||||
| Net loss |
$ |
(35,460) |
$ |
(87,126) |
|
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization |
|
129 |
|
1,547 |
|
| (Gain) loss on sale of property and equipment, net |
|
(12) |
|
59 |
|
| Noncash lease expense relating to operating lease right-of-use assets |
|
956 |
|
1,406 |
|
| Gain on termination of operating lease, net |
|
(491) |
|
(35) |
|
| Impairment of long-lived assets |
|
— |
|
9,988 |
|
| Common stock purchase agreement costs |
|
1,124 |
|
— |
|
| Inventory write-downs, net of scrapped inventory |
|
161 |
|
7,712 |
|
| Loss on advances to suppliers |
|
— |
|
1,385 |
|
| Change in fair value of convertible note and warrant liabilities |
|
— |
|
858 |
|
| Realized loss on instrument-specific credit risk |
|
— |
|
46 |
|
| Stock-based compensation |
|
9,047 |
|
18,071 |
|
| Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest |
|
(611) |
|
(211) |
|
| Expected credit losses, net of write-off |
|
35 |
|
35 |
|
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net |
|
85 |
|
451 |
|
| Inventories, current and noncurrent, net |
|
245 |
|
(2,459) |
|
| Prepaid and other current assets |
|
1,490 |
|
2,279 |
|
| Other noncurrent assets |
|
215 |
|
284 |
|
| Accounts payable |
|
156 |
|
252 |
|
| Accrued expenses and other current liabilities |
|
(2,389) |
|
(3,135) |
|
| Operating lease liabilities |
|
(955) |
|
(1,528) |
|
| Contract liabilities |
|
— |
|
(987) |
|
| Other noncurrent liabilities |
|
(345) |
|
383 |
|
| Net cash used in operating activities |
|
(26,620) |
|
(50,725) |
|
| Cash flows from investing activities: | |||||
| Purchases of property and equipment |
|
(486) |
|
(1,951) |
|
| Proceeds from sale of property and equipment |
|
45 |
|
283 |
|
| Purchases of marketable securities |
|
(24,241) |
|
(19,331) |
|
| Proceeds from redemptions and maturities of marketable securities |
|
32,426 |
|
76,350 |
|
| Net cash provided by investing activities |
|
7,744 |
|
55,351 |
|
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options |
|
134 |
|
455 |
|
| Proceeds from the issuance of convertible note |
|
146 |
|
— |
|
| Payments for convertible note redemptions |
|
— |
|
(6,235) |
|
| Taxes paid related to the net share settlement of equity awards |
|
(161) |
|
(1,445) |
|
| Proceeds from issuance of common stock under the Common Stock Purchase Agreements |
|
11,080 |
|
136 |
|
| Stock issuance costs related to the Common Stock Purchase Agreements |
|
(1,232) |
|
(3) |
|
| Proceeds from issuance of common stock through the Employee Stock Purchase Plan |
|
93 |
|
334 |
|
| Net cash provided by (used in) financing activities |
|
10,060 |
|
(6,758) |
|
| Net decrease in cash, cash equivalents and restricted cash |
|
(8,816) |
|
(2,132) |
|
| Cash, cash equivalents and restricted cash at beginning of period |
|
19,082 |
|
21,214 |
|
| Cash, cash equivalents and restricted cash at end of period |
$ |
10,266 |
$ |
19,082 |
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||
| Three months ended |
Twelve months ended |
||||||||||
|
2024 |
2023 |
2024 |
2023 |
||||||||
| GAAP net loss |
$ |
(8,548) |
$ |
(27,782) |
$ |
(35,460) |
$ |
(87,126) |
|||
| Non-GAAP adjustments: | |||||||||||
| Stock-based compensation |
|
2,045 |
|
3,364 |
|
9,047 |
|
18,071 |
|||
| Expenses related to registration statements and common stock purchase agreements |
|
(12) |
|
(50) |
|
1,124 |
|
183 |
|||
| Change in fair value of convertible note and warrant liabilities |
|
(4) |
|
(56) |
|
— |
|
858 |
|||
| Realized loss on instrument-specific credit risk |
|
— |
|
— |
|
— |
|
46 |
|||
| One-time termination benefits and other restructuring costs |
|
— |
|
1,877 |
|
— |
|
3,347 |
|||
| Non-routine write-downs of inventory, other current assets and losses on purchase commitments |
|
— |
|
5,621 |
|
— |
|
8,628 |
|||
| Long-lived asset disposals and impairment charges |
|
— |
|
10,185 |
|
— |
|
10,232 |
|||
| Loss (gain) on termination of operating lease, net |
|
189 |
|
(35) |
|
(491) |
|
(35) |
|||
| Non-GAAP net loss |
$ |
(6,330) |
$ |
(6,876) |
$ |
(25,780) |
$ |
(45,796) |
|||
| Depreciation and amortization expense |
|
49 |
|
304 |
|
129 |
|
1,302 |
|||
| Interest income and other |
|
(143) |
|
(350) |
|
(799) |
|
(1,282) |
|||
| Interest expense and other |
|
(284) |
|
(210) |
|
(691) |
|
(294) |
|||
| (Benefit) provision for income tax |
|
(4) |
|
14 |
|
(2) |
|
57 |
|||
| Adjusted EBITDA |
$ |
(6,712) |
$ |
(7,118) |
$ |
(27,143) |
$ |
(46,013) |
|||
| GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
$ |
(0.93) |
$ |
(4.44) |
$ |
(4.89) |
$ |
(14.95) |
|||
| Non-GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
$ |
(0.69) |
$ |
(1.10) |
$ |
(3.55) |
$ |
(7.86) |
|||
| Shares used in computing GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
|
9,144,094 |
|
6,257,793 |
|
7,253,683 |
|
5,827,721 |
|||
| Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
|
9,144,094 |
|
6,257,793 |
|
7,253,683 |
|
5,827,721 |
|||
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220092786/en/
Investor Relations Contacts:
Agency Contact
Financial
eniu@finprofiles.com
310-622-8243
Company Contact
info@aeye.ai
925-400-4366
Source: